Clinical Trial Update: Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating skin irritation of LEO 90100 Foam (calcipotriol hydrate plus betamethasone dipropionate) in healthy Japanese volunteers, focusing on to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• LEO 90100 Foam

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 1 | Status: COMPLETED